Thought Leadership

Short-term fix or long-term fixture for clinical trials?

In the last two years, accelerated by COVID-19, native advertising has ignited

How immersive learning experiences can support and elevate patient-centricity goals in the pharma industry

Patient centricity that delivers the ‘triple win’ is a business essential for pharma

Sue Thomas explains how Wilmington Healthcare’s unique behavioural methodology is helping to define best practice pathways for patients with chronic kidney disease (CKD) during the pandemic

Steve How explains how Wilmington Healthcare’s unique behavioural methodology is being used to map patient journeys across the integrated care landscape

Life science companies were challenged by the sudden shift in ways of working as the COVID-19 pandemic began. But in moving critical work and even some large-scale events to virtual platforms, pharmaceutical teams learned valuable lessons and embraced new technologies that will become part of their long-term strategy.

The COVID-19 pandemic has brought into question how we approach care across multiple disease areas in the future. But what does this mean in cancer? Hear from Bristol Myers Squibb’s (BMS) Executive Medical Director, Hubert Bland, who believes that in order to advance in cancer care, we must learn from the COVID-19 response and adopt a collaborative approach across the healthcare industry.

To deliver high standards of support to healthcare professionals we have to be both digitally-savvy and relationship-smart

Dr Jason Raw outlines key findings from the SYNPASES trial, which explored the tolerability of safinamide used as an adjunct therapy in patients with Parkinson’s disease

The global COVID pandemic has highlighted the need for expert leadership in global healthcare. Oxford University is rising to the challenge, pulling together specialists from business and medical departments to launch an MSc in Global Healthcare Leadership

Ipsen Pharmaceuticals’ Global Digital Health Partnerships Lead, Dr Myles Furnace, discusses the company’s new partnership with digital health specialists Mendelian, which aims to improve the speed of diagnosis of rare diseases

ICON’s Michael Pellegrino outlines research looking at patient involvement in journal review processes

Imaginatively designed content combined with patient insights delivers campaigns that inspire behaviour change